Page last updated: 2024-10-25

dapsone and Angiitis

dapsone has been researched along with Angiitis in 42 studies

Research Excerpts

ExcerptRelevanceReference
"ARAMIS is a multicenter, sequential, multiple assignment randomized trial with an enrichment design (SMARTER) aimed at comparing the efficacy of three drugs-azathioprine, colchicine, and dapsone-commonly used to treat various forms of isolated skin vasculitis."9.34Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone. ( Borchin, R; Grayson, PC; Krischer, JP; McAlear, CA; Merkel, PA; Micheletti, RG; Pagnoux, C; Tamura, RN, 2020)
"Dapsone has potent anti-inflammatory effects, and is used in the treatment of leprosy, cutaneous vasculitis, neutrophilic dermatoses, and dermatitis herpetiformis and other blistering disorders."7.75Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies. ( Chun, JS; Kim, SJ; Lee, JB; Lee, SC; Won, YH; Yun, SJ, 2009)
" We describe the clinical, serologic and immunogenetic data in a patient with manifestations of Sjögren's syndrome who developed urticarial vasculitis and photosensitive annular SCLE which were effectively treated with oral dapsone."7.68Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. ( Callen, JP; Holtman, JH; Klein, J; Neustadt, DH, 1990)
"Dapsone 100 mg daily led to a rapid and complete clearing of extensive vasculitic urticarial lesions in a female patient with systemic lupus erythematosus."7.66Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. ( Goerz, G; Ruzicka, T, 1981)
" Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection."6.50Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014)
"ARAMIS is a multicenter, sequential, multiple assignment randomized trial with an enrichment design (SMARTER) aimed at comparing the efficacy of three drugs-azathioprine, colchicine, and dapsone-commonly used to treat various forms of isolated skin vasculitis."5.34Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone. ( Borchin, R; Grayson, PC; Krischer, JP; McAlear, CA; Merkel, PA; Micheletti, RG; Pagnoux, C; Tamura, RN, 2020)
"Dapsone has potent anti-inflammatory effects, and is used in the treatment of leprosy, cutaneous vasculitis, neutrophilic dermatoses, and dermatitis herpetiformis and other blistering disorders."3.75Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies. ( Chun, JS; Kim, SJ; Lee, JB; Lee, SC; Won, YH; Yun, SJ, 2009)
" We describe the clinical, serologic and immunogenetic data in a patient with manifestations of Sjögren's syndrome who developed urticarial vasculitis and photosensitive annular SCLE which were effectively treated with oral dapsone."3.68Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. ( Callen, JP; Holtman, JH; Klein, J; Neustadt, DH, 1990)
"Dapsone therapy for leukocytoclastic (necrotizing) vasculitis has been little used, except for the variant forms of erythema elevatum diutinum and urticarial vasculitis."3.67Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases. ( Fredenberg, MF; Malkinson, FD, 1987)
"Dapsone 100 mg daily led to a rapid and complete clearing of extensive vasculitic urticarial lesions in a female patient with systemic lupus erythematosus."3.66Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. ( Goerz, G; Ruzicka, T, 1981)
" Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection."2.50Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014)
"Advances in the diagnosis and treatment of vasculitis will also be discussed."2.38Immune-complex vasculitis: role of complement and IgG-Fc receptor functions. ( Moore, SE; Smiley, JD, 1989)
"Envenomation may induce a generalized exanthem known clinically but not described histologically."1.34Generalized vasculitic exanthem following Loxosceles reclusa envenomation. ( Boyd, AS; Hayes, BB; Robb, CW, 2007)

Research

Studies (42)

TimeframeStudies, this research(%)All Research%
pre-199011 (26.19)18.7374
1990's9 (21.43)18.2507
2000's11 (26.19)29.6817
2010's8 (19.05)24.3611
2020's3 (7.14)2.80

Authors

AuthorsStudies
Yoshida, M1
Nambu, R1
Yasuda, R1
Sakaguchi, H1
Hara, T1
Iwama, I1
Mizuochi, T1
Tabata, MM1
Lin, WM1
Goldstein, J1
Quinn, TR1
Chen, ST1
Ramelli, V1
Rinoldi, PO1
Bianchetti, MG1
Lava, SAG1
Ramelli, GP1
Milani, GP1
Roman, C1
Dima, B1
Muyshont, L1
Schurmans, T1
Gilliaux, O1
Micheletti, RG1
Pagnoux, C1
Tamura, RN1
Grayson, PC1
McAlear, CA1
Borchin, R1
Krischer, JP1
Merkel, PA1
Lee, KH1
Park, JH1
Kim, DH1
Hwang, J1
Lee, G1
Hyun, JS1
Heo, ST1
Choi, JH1
Kim, M2
Kim, SI1
Eisenhut, M1
Kronbichler, A1
Shin, JI1
Gusdorf, L1
Lipsker, D1
Yates, M1
Loke, YK1
Watts, RA1
MacGregor, AJ1
Christiansen, J1
Kahn, R1
Schmidtchen, A1
Berggård, K1
Schulkes, KJ1
Tervaert, JW1
Rijken, F1
Haas, LE1
Fujimoto, M1
Asano, Y1
Ishii, T1
Ogawa, F1
Kawakami, T1
Kodera, M1
Abe, M1
Isei, T1
Ito, T1
Inoue, Y1
Imafuku, S1
Irisawa, R1
Ohtsuka, M2
Kadono, T1
Kawaguchi, M1
Kukino, R1
Kono, T1
Sakai, K1
Takahara, M1
Tanioka, M1
Nakanishi, T1
Nakamura, Y1
Hashimoto, A1
Hasegawa, M1
Hayashi, M1
Fujiwara, H1
Maekawa, T1
Matsuo, K1
Madokoro, N1
Yamasaki, O1
Yoshino, Y1
Le Pavoux, A1
Tachibana, T1
Ihn, H1
Chun, JS1
Yun, SJ1
Kim, SJ1
Lee, SC1
Won, YH1
Lee, JB1
Francès, C1
Barete, S1
Ayoub, N1
Piette, JC1
Seybold, H1
Simon, M1
Schuler, G1
Lüftl, M1
Lee, JS1
Loh, TH1
Seow, SC1
Tan, SH1
Robb, CW1
Hayes, BB1
Boyd, AS1
Miyachi, Y1
Yanase, K1
Imamura, S1
Niwa, Y1
Ruzicka, T1
Goerz, G1
Valente, RM1
Conn, DL1
Erdi, H1
Anadolu, R1
Pişkin, G1
Gürgey, E1
Lotti, T1
Ghersetich, I1
Comacchi, C1
Jorizzo, JL1
Nakajima, H1
Ikeda, M1
Yamamoto, Y1
Kodama, H1
Cadnapaphornchai, MA1
Saulsbury, FT2
Norwood, VF1
Hart, MH1
Galaria, NA1
Junkins-Hopkins, JM1
Kligman, D1
James, WD1
Delgado, J1
Gómez-Cerezo, J1
Sigüenza, M1
Barbado, FJ1
Dupond, JL1
Vazquez, JJ1
Ling, TC1
Kendra, JR1
Al-Dawoud, A1
Coulson, IH1
DiCaudo, DJ1
Connolly, SM1
Tanzer, FR1
Lynfield, YL1
Dewar, CL1
Bellamy, N1
González Quijada, S1
López Lázaro, L1
Reinares García, L1
Borregón Carretero, SJ1
Sastre Varela, J1
Estrada Pérez, V1
Barlow, RJ1
Schulz, EJ1
Joubert, B1
Devant, O1
Amblard, P1
Holtman, JH1
Neustadt, DH1
Klein, J1
Callen, JP1
Smiley, JD1
Moore, SE1
Faulhaber, G1
Lechner, W1
Bernard, P1
Arnaud, M1
Treves, R1
Bonnetblanc, JM1
Fredenberg, MF1
Malkinson, FD1
Fortson, JS1
Zone, JJ1
Hammond, ME1
Groggel, GC1
Frucht, U1
Gramm, HJ1
Dennhardt, R1
Asghar, SS1
Westerhof, W1
Das, PK1
Jansen, FC1
Cormane, RH1
Muramatsu, C1
Tanabe, E1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized Multicenter Study for Isolated Skin Vasculitis[NCT02939573]Phase 290 participants (Anticipated)Interventional2017-01-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

5 reviews available for dapsone and Angiitis

ArticleYear
Neutrophilic urticarial dermatosis: A review.
    Annales de dermatologie et de venereologie, 2018, Volume: 145, Issue:12

    Topics: Arthralgia; Colchicine; Cryopyrin-Associated Periodic Syndromes; Dapsone; Dermis; Diagnosis, Differe

2018
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
    Clinical rheumatology, 2014, Volume: 33, Issue:2

    Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dap

2014
Current therapies for systemic vasculitis.
    Seminars in neurology, 1994, Volume: 14, Issue:4

    Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunization, Passive;

1994
Cutaneous small-vessel vasculitis.
    Journal of the American Academy of Dermatology, 1998, Volume: 39, Issue:5 Pt 1

    Topics: Aminocaproates; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antigen-Antibody Co

1998
Immune-complex vasculitis: role of complement and IgG-Fc receptor functions.
    The American journal of the medical sciences, 1989, Volume: 298, Issue:4

    Topics: Cyclophosphamide; Dapsone; Humans; Immune Complex Diseases; Immunoglobulin G; Methotrexate; Receptor

1989

Trials

1 trial available for dapsone and Angiitis

ArticleYear
Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone.
    Trials, 2020, Apr-28, Volume: 21, Issue:1

    Topics: Azathioprine; Colchicine; Cross-Over Studies; Dapsone; Drug Resistance; Humans; Multicenter Studies

2020

Other Studies

36 other studies available for dapsone and Angiitis

ArticleYear
Dapsone for Refractory Gastrointestinal Symptoms in Children With Immunoglobulin A Vasculitis.
    Pediatrics, 2022, 09-01, Volume: 150, Issue:3

    Topics: Abdominal Pain; Adrenal Cortex Hormones; Child; Dapsone; Gastrointestinal Diseases; Humans; IgA Vasc

2022
Localised chronic fibrosing vasculitis versus erythema elevatum diutinum.
    BMJ case reports, 2023, Jan-02, Volume: 16, Issue:1

    Topics: Dapsone; Erythema; Female; Fibrosis; Granuloma; Humans; Plasma Cells; Vasculitis; Vasculitis, Leukoc

2023
Dapsone in immunoglobulin A-associated vasculitis.
    European journal of pediatrics, 2019, Volume: 178, Issue:12

    Topics: Dapsone; Humans; IgA Vasculitis; Immunoglobulin A; Vasculitis; Vasculitis, Leukocytoclastic, Cutaneo

2019
Authors' response to correspondence entitled "Dapsone in immunoglobulin A-associated vasculitis".
    European journal of pediatrics, 2019, Volume: 178, Issue:12

    Topics: Dapsone; Humans; Immunoglobulin A; Vasculitis

2019
Dapsone as a potential treatment option for Henoch-Schönlein Purpura (HSP).
    Medical hypotheses, 2017, Volume: 108

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Chemotaxis; Cytokines; Dapsone; Free Radicals; Hu

2017
Idiopathic angioedema and urticarial vasculitis in a patient with a history of acquired haemophilia.
    Acta dermato-venereologica, 2015, Volume: 95, Issue:2

    Topics: Aged; Angioedema; Autoimmunity; Azathioprine; Colchicine; Dapsone; Drug Therapy, Combination; Hemoph

2015
Dapsone hypersensitivity syndrome not related to G6PD deficiency.
    BMJ case reports, 2015, Dec-18, Volume: 2015

    Topics: Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Dapsone; Diagnosis, Differential; Dru

2015
The wound/burn guidelines - 4: Guidelines for the management of skin ulcers associated with connective tissue disease/vasculitis.
    The Journal of dermatology, 2016, Volume: 43, Issue:7

    Topics: Antithrombins; Calcinosis; Calcium Channel Blockers; Connective Tissue Diseases; Dapsone; Endothelin

2016
Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies.
    Clinical and experimental dermatology, 2009, Volume: 34, Issue:8

    Topics: Adult; Autoantibodies; Dapsone; Dermatologic Agents; Drug Eruptions; Female; Humans; Hypersensitivit

2009
[Classification of dermatologic manifestations in lupus erythematosus].
    Annales de medecine interne, 2003, Volume: 154, Issue:1

    Topics: Acitretin; Adrenal Cortex Hormones; Adult; Antimalarials; Clinical Trials as Topic; Dapsone; Dermato

2003
[Refractory cutaneous necrotizing vasculitis. Successful sulfone therapy].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2006, Volume: 57, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Resistance; Female; Humans; Necrosis;

2006
Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis.
    Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; Blood Vessels; Colchicine; Daps

2007
Generalized vasculitic exanthem following Loxosceles reclusa envenomation.
    Journal of cutaneous pathology, 2007, Volume: 34, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cryotherapy; Dapsone; Drug Therapy, Combi

2007
Increased hydroxyl radical generation by normal polymorphonuclear leukocytes incubated in sera from patients with leukocytoclastic vasculitis.
    Archives of dermatological research, 1982, Volume: 274, Issue:1-2

    Topics: Adult; Antigen-Antibody Complex; Dapsone; Female; Free Radicals; Humans; In Vitro Techniques; Male;

1982
Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels.
    Dermatologica, 1981, Volume: 162, Issue:3

    Topics: Adult; Complement System Proteins; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Urticaria

1981
Malignant pyoderma: a clinical variant of pyoderma gangrenosum.
    International journal of dermatology, 1996, Volume: 35, Issue:11

    Topics: Adrenal Cortex Hormones; Adult; Clofazimine; Dapsone; Female; Folliculitis; Humans; Pyoderma Gangren

1996
Erythema elevatum diutinum complicated by rheumatoid arthritis.
    The Journal of dermatology, 1999, Volume: 26, Issue:7

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dapsone; E

1999
Hypocomplementemic urticarial vasculitis: report of a pediatric case.
    Pediatric nephrology (Berlin, Germany), 2000, Volume: 14, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Child; Complement System Proteins; Dapsone; Fema

2000
Crohn's disease presenting with Henoch-Schönlein purpura.
    Journal of pediatric gastroenterology and nutrition, 2000, Volume: 31, Issue:2

    Topics: Adolescent; Biopsy; Blood Vessels; Colon; Complement C3; Crohn Disease; Dapsone; Endoscopy, Gastroin

2000
Neutrophilic dermatosis of the dorsal hands: pustular vasculitis revisited.
    Journal of the American Academy of Dermatology, 2000, Volume: 43, Issue:5 Pt 1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Blister; Dapsone; Diagnosis, Differential; Female; Hand; Hu

2000
Relapsing polychondritis and erythema elevatum diutinum: an unusual association refractory to dapsone.
    The Journal of rheumatology, 2001, Volume: 28, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Female; Humans; Polychondritis, Relapsing;

2001
Lichenoid vasculitis associated with myeloproliferative disorder: successful treatment with dapsone.
    The British journal of dermatology, 2001, Volume: 145, Issue:2

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone; Humans; Leg Dermatoses; Lic

2001
Neutrophilic dermatosis (pustular vasculitis) of the dorsal hands: a report of 7 cases and review of the literature.
    Archives of dermatology, 2002, Volume: 138, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Fe

2002
Erythema elevatum diutinum.
    Archives of dermatology, 1978, Volume: 114, Issue:5

    Topics: Aged; Arthritis, Rheumatoid; Dapsone; Erythema; Humans; Leg Ulcer; Male; Prednisone; Skin Diseases;

1978
Necrotizing mesenteric vasculitis after longstanding cutaneous polyarteritis nodosa.
    The Journal of rheumatology, 1992, Volume: 19, Issue:8

    Topics: Adult; Azathioprine; Cyclophosphamide; Dapsone; Female; Humans; Mesenteric Arteries; Methotrexate; N

1992
[Gastrointestinal involvement and the response to dapsone in a case of the urticarial vasculitis syndrome].
    Medicina clinica, 1991, Nov-23, Volume: 97, Issue:18

    Topics: Adult; Chronic Disease; Dapsone; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Human

1991
Chronic subcorneal pustulosis with vasculitis: a variant of generalized pustular psoriasis in black South Africans.
    The British journal of dermatology, 1991, Volume: 124, Issue:5

    Topics: Adult; Black People; Child; Dapsone; Female; Humans; Middle Aged; Prednisolone; Psoriasis; Retrospec

1991
[Disulone: focus on its indications in dermatology].
    Annales de dermatologie et de venereologie, 1990, Volume: 117, Issue:1

    Topics: Dapsone; Granuloma; Humans; Lichen Planus; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Syst

1990
Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
    The Journal of rheumatology, 1990, Volume: 17, Issue:9

    Topics: Administration, Oral; Adult; Complement C2; Dapsone; Female; Humans; Lupus Erythematosus, Cutaneous;

1990
[Urticaria-vasculitis with bullous eruptions in visceral lupus erythematosus].
    Zeitschrift fur Hautkrankheiten, 1987, Jun-01, Volume: 62, Issue:11

    Topics: Adult; Antigen-Antibody Complex; Biopsy; Dapsone; Drug Therapy, Combination; Female; Fluorescent Ant

1987
Dapsone and rheumatoid vasculitis leg ulcerations.
    Journal of the American Academy of Dermatology, 1988, Volume: 18, Issue:1 Pt 1

    Topics: Adult; Aged; Arthritis, Rheumatoid; Dapsone; Female; Humans; Leg Ulcer; Vasculitis

1988
Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases.
    Journal of the American Academy of Dermatology, 1987, Volume: 16, Issue:4

    Topics: Adolescent; Blood Vessels; Dapsone; Female; Humans; IgA Vasculitis; Middle Aged; Skin; Vasculitis

1987
Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone.
    Journal of the American Academy of Dermatology, 1986, Volume: 15, Issue:5 Pt 2

    Topics: Arthritis; Complement System Proteins; Dapsone; Female; Glomerulonephritis; Humans; Kidney Glomerulu

1986
[Toxic methemoglobinemia following the postoperative ingestion of 4,4-diaminodiphenylsulfone (DADPS)--on the differential diagnosis of cyanosis].
    Anasthesie, Intensivtherapie, Notfallmedizin, 1985, Volume: 20, Issue:1

    Topics: Adult; Cyanosis; Dapsone; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Me

1985
Treatment of vasculitis with chlorpromazine and dapsone.
    Archives of dermatological research, 1985, Volume: 277, Issue:6

    Topics: Chlorpromazine; Complement C3; Dapsone; Female; Humans; Immunoglobulin A; Middle Aged; Vasculitis

1985
Urticarial vasculitis: response to dapsone and colchicine.
    Journal of the American Academy of Dermatology, 1985, Volume: 13, Issue:6

    Topics: Colchicine; Dapsone; Female; Humans; Middle Aged; Urticaria; Vasculitis

1985